EGFR, which acts upstream of the STAT3 signaling pathway, is overexpressed in 80% to 90% of HNSCC tumors and is linked to an overall decrease in survival and progression-free survival [106,107]. Here, STAT3 is linked to head and neck squamous cell carcinoma.